A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed ... and has been administered in a twice-daily dosing regimen in clinical trials without the need for ...

Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings ...

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

SINGAPORE – Guidelines to manage the use of screens among young children have been updated by the Ministry of Health, to provide stricter and clearer advice for parents. This is part of a newly ...

Higher PPI dosages improve outcomes in those with gastroesophageal disease, but it is unclear whether twice-daily dosing is more effective.

Methods We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Clinicaltrials.gov, the WHO International Clinical Trials Registry Platform and bibliographies of included trials, ...

These dosages may be taken once a day, in divided doses, or as directed by your healthcare provider. Dosage guidelines for constipation: For adults and children aged 12 and older, the recommended ...